Previous close | 11.27 |
Open | 11.23 |
Bid | 8.13 x 200 |
Ask | 14.16 x 200 |
Day's range | 11.01 - 11.24 |
52-week range | 5.22 - 12.50 |
Volume | |
Avg. volume | 969,116 |
Market cap | 2.283B |
Beta (5Y monthly) | 1.51 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.43 |
Earnings date | 15 Feb 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 13.58 |
Key Insights The projected fair value for Cellebrite DI is US$16.82 based on 2 Stage Free Cash Flow to Equity...
TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 10, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its first-quarter 2024 financial results before market open on Thursday, May 23, 2024. Later that same morning, Cellebrite will host a live conference call and webcast to review the Company's financial results for the first quarter of 2024 and discuss its 2024 outlook
Cellebrite DI Ltd. ( NASDAQ:CLBT ), is not the largest company out there, but it received a lot of attention from a...